GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Inventory-to-Revenue
中文

Awakn Life Sciences (Awakn Life Sciences) Inventory-to-Revenue

: 0.00 (As of Oct. 2023)
View and export this data going back to 2021. Start your Free Trial

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Awakn Life Sciences's Average Total Inventories for the quarter that ended in Oct. 2023 was $0.00 Mil. Awakn Life Sciences's Revenue for the three months ended in Oct. 2023 was $0.02 Mil. Awakn Life Sciences's Inventory-to-Revenue for the quarter that ended in Oct. 2023 was 0.00.

Awakn Life Sciences's Inventory-to-Revenue for the quarter that ended in Oct. 2023 stayed the same from Jul. 2023 (0.00) to Jul. 2023 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Awakn Life Sciences Inventory-to-Revenue Historical Data

The historical data trend for Awakn Life Sciences's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23
Inventory-to-Revenue
- - -

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Biotechnology subindustry, Awakn Life Sciences's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences Inventory-to-Revenue Distribution

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Inventory-to-Revenue falls into.



Awakn Life Sciences Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Awakn Life Sciences's Inventory-to-Revenue for the fiscal year that ended in Jan. 2023 is calculated as

Inventory-to-Revenue (A: Jan. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Jan. 2022 ) + Total Inventories (A: Jan. 2023 )) / count ) / Revenue (A: Jan. 2023 )
=( (0 + 0) / 1 ) / 1.114
=0 / 1.114
=0.00

Awakn Life Sciences's Inventory-to-Revenue for the quarter that ended in Oct. 2023 is calculated as

Inventory-to-Revenue (Q: Oct. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jul. 2023 ) + Total Inventories (Q: Oct. 2023 )) / count ) / Revenue (Q: Oct. 2023 )
=( (0 + 0) / 1 ) / 0.021
=0 / 0.021
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences  (OTCPK:AWKNF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Awakn Life Sciences's Days Inventory for the three months ended in Oct. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Oct. 2023 )/Cost of Goods Sold (Q: Oct. 2023 )*Days in Period
=0/0*365 / 4
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Awakn Life Sciences's Inventory Turnover for the quarter that ended in Oct. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Oct. 2023 ) / Average Total Inventories (Q: Oct. 2023 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines